Guodong Li
State Key Laboratory Of Holistic Integrative Management Of Gastrointestinal Cancers
Xi'an, China
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
SPP1-positive macrophages drive trastuzumab resistance in HER2-positive breast cancer.
Journal: Cell communication and signaling : CCS
Published: February 09, 2026
Targeting PDPN+ CAFs enhances treatment efficacy of trastuzumab by reversing immunosuppressive microenvironment in HER2-positive breast cancer.
Journal: International immunopharmacology
Published: August 23, 2025
CD48 is a novel immune checkpoint on tumour-associated macrophages in hepatocellular carcinoma.
Journal: Gut
Published: August 19, 2025
NK cell immunopotentiators-loaded nanoliposomes enhance ADCC effect for targeted therapy against HER2-positive breast cancer.
Journal: Cell communication and signaling : CCS
Published: October 04, 2024
Improved Efficacy of Triple-Negative Breast Cancer Immunotherapy via Hydrogel-Based Co-Delivery of CAR-T Cells and Mitophagy Agonist.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 18, 2024
Inhibition of METTL14 overcomes CDK4/6 inhibitor resistance driven by METTL14-m6A-E2F1-axis in ERα-positive breast cancer.
Journal: Journal of nanobiotechnology
Published: July 01, 2024
CXCL12+ tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma.
Journal: Journal of hepatology
Published: March 25, 2024
Research progress on hydrogel-based drug therapy in melanoma immunotherapy.
Journal: BMB reports
Published: September 18, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026